Just three months after the start of the coronavirus pandemic, several biotech companies are beginning trials of promising vaccines and treatments.
Tag: Clinical Trials
Hydroxychloroquine and Coronavirus: Fact-Check on the Malaria Drug Trump Keeps Pushing
Here are the facts on hydroxychloroquine, which the president has promoted despite little evidence that it works against the coronavirus.
Can an Old Vaccine Stop the New Coronavirus?
A tuberculosis vaccine invented a century ago is cheap and safe, and seems to bolster the body’s immune system.
Covid-19 Changed How the World Does Science, Together
Never before, scientists say, have so many of the world’s researchers focused so urgently on a single topic. Nearly all other research has ground to a halt.
Coronavirus Patients in Limbo as Gilead Suspends Emergency Drug Access
The company says it will switch to a broader approach for its experimental drug, remdesivir. But it was overwhelmed by demand for a potential treatment promoted by President Trump.
Gilead to Expand Coronavirus Drug Trials to Other Countries
The drug maker said that in March it would begin two more clinical trials of remdesivir, an experimental antiviral drug, in more nations outside China.
An Alzheimer’s Treatment Fails: ‘We Don’t Have Anything Now’
With high hopes, drugs to fight brain plaques were tested in people genetically destined to develop dementia. The drugs failed.
Researchers Are Racing to Make a Coronavirus Vaccine. Will It Help?
New technology and better coordination have sped up development. But a coronavirus vaccine is still months — and most likely years — away.
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Once, a diagnosis of extensively drug-resistant TB meant quick death. A three-drug regimen cures most patients in just months.
A Cure for Ebola? Two New Treatments Prove Highly Effective in Congo
The therapies saved roughly 90 percent of the patients who were newly infected, a turning point in the decades-long fight against the virus.